US Patent

US9840492 — Antifungal compounds and processes for making

Composition of Matter · Assigned to Viamet Pharmaceuticals Inc · Expires 2036-03-17 · 10y remaining

Vulnerability score 12/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects new polymorphic forms of the antifungal compound and processes for making them.

USPTO Abstract

The present invention relates to polymorphic forms of compound 1 or 1a and processes for preparing compound 1 and 1a polymorphs, which are useful as antifungal agents. In particular, the invention seeks to provide a new methodology for preparing polymorphs of compound 1 and substituted derivatives thereof.

Drugs covered by this patent

Patent Metadata

Patent number
US9840492
Jurisdiction
US
Classification
Composition of Matter
Expires
2036-03-17
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Viamet Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.